MCID: APR001
MIFTS: 51

Apraxia malady

Categories: Rare diseases, Mental diseases

Aliases & Classifications for Apraxia

About this section

Summaries for Apraxia

About this section
NIH Rare Diseases:48 Apraxia is a neurological disorder characterized by the inability to perform tasks or movements, despite having the desire and physical ability to perform them. it is caused by damage to the brain, especially the parietal lobe, and can arise from many diseases, tumors, a stroke, or traumatic brain injury. in some cases it is present from birth. there are several types of apraxia, which may occur alone or together. these include:buccofacial or orofacial apraxia is the inability to carry out facial movements on demand. this may include licking the lips, sticking out the tongue, whistling, coughing, or winking. ideational apraxia is the inability to carryout learned, complex tasks with multiple, sequential movements. this may include dressing, eating, and bathing. ideomotor apraxia is the inability to perform a learned task (such as using a tool) or communicate using gestures (like waving good-bye). limb-kinetic apraxia is the inability to make fine, precise movements with an arm or leg. this may include buttoning a shirt or tying a shoe.  verbal apraxia is difficulty coordinating mouth and speech movements. verbal apraxia may be acquired or present from birth. constructional apraxia is the inability to copy, draw, or construct simple figures. oculomotor apraxia is difficulty moving the eyes on command. treatment of apraxia may include physical, speech, or occupational therapy. if apraxia occurs as a symptom of another disorder, treatment should be directed to the underlying condition. last updated: 1/4/2016

MalaCards based summary: Apraxia, also known as apraxias, is related to coenzyme q10 deficiency, primary, 1 and ideomotor apraxia, and has symptoms including cachexia, cachexia and cyanosis. An important gene associated with Apraxia is APTX (Aprataxin), and among its related pathways is Canonical NF-kappaB pathway. Affiliated tissues include brain, parietal lobe and cortex, and related mouse phenotypes are Decreased viability with poly (ADPa89ribose)a89polymerasea891 (PARP) inhibitor and taste/olfaction.

NINDS:49 Apraxia (called "dyspraxia" if mild) is a neurological disorder characterized by loss of the ability to execute or carry out skilled movements and gestures, despite having the desire and the physical ability to perform them. Apraxia results from dysfunction of the cerebral hemispheres of the brain, especially the parietal lobe, and can arise from many diseases or damage to the brain.

Disease Ontology:11 An agnosia that is a loss of the ability to map out physical actions in order to repeat them in functional activities.

Wikipedia:71 Apraxia is a motor disorder caused by damage to the brain (specifically the posterior parietal cortex),... more...

Related Diseases for Apraxia

About this section

Diseases related to Apraxia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 170)
idRelated DiseaseScoreTop Affiliating Genes
1coenzyme q10 deficiency, primary, 131.0APOE, GRN, MAPT
2ideomotor apraxia12.3
3childhood apraxia of speech12.2
4ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia12.2
5ocular motor apraxia12.2
6rolandic epilepsy, mental retardation, and speech dyspraxia12.1
7ataxia-oculomotor apraxia 312.1
8ataxia-oculomotor apraxia 412.1
9gait apraxia12.0
10primary progressive apraxia of speech11.8
11autosomal recessive cerebellar ataxia-pyramidal signs-nystagmus-oculomotor apraxia syndrome11.7
12x-linked intellectual disability-ataxia-apraxia syndrome11.7
13spinocerebellar ataxia, autosomal recessive 111.6
14agnosia11.4
15foxp2-related speech and language disorders11.4
16poretti-boltshauser syndrome11.3
17balint syndrome11.3
18ataxia-telangiectasia11.1
19corticobasal degeneration11.1
20wieacker-wolff syndrome11.0
21agraphia10.9
22alzheimer disease, type 310.9
23intellectual disability-developmental delay-contractures syndrome10.8
24spinocerebellar ataxia with axonal neuropathy type 210.8
25joubert syndrome 1610.8
26joubert syndrome 210.8
27joubert syndrome 1510.8
28joubert syndrome 2110.8
29joubert syndrome 610.8
30joubert syndrome 110.8
31mitochondrial complex iii deficiency, nuclear type 210.8
32ataxia, spastic, 5, autosomal recessive10.8
33joubert syndrome 2510.8
34progressive supranuclear palsy-progressive non-fluent aphasia syndrome10.7
35joubert syndrome 410.6
36nephronophthisis 1210.6
37joubert syndrome 2210.6
38joubert syndrome 810.6
39joubert syndrome 910.6
40joubert syndrome 1710.6
41frontotemporal dementia and/or amyotrophic lateral sclerosis 310.6
42joubert syndrome-310.6
43joubert syndrome 1810.6
44ataxia-telangiectasia-like disorder10.6
45frontotemporal dementia and/or amyotrophic lateral sclerosis 410.6
46joubert syndrome 510.6
47joubert syndrome 1310.6
48pick disease10.6
49acrocallosal syndrome10.6
50nephronophthisis 1410.6

Graphical network of the top 20 diseases related to Apraxia:



Diseases related to apraxia

Symptoms & Phenotypes for Apraxia

About this section

UMLS symptoms related to Apraxia:


cachexia, cyanosis, dyspnea, edema, fever, headache, icterus, muscle rigidity, seizures, signs and symptoms, signs and symptoms, digestive, syncope, torticollis, vertigo, clumsiness, abnormality of extrapyramidal motor function, reduced consciousness/confusion, other symbolic dysfunction, hot flushes, symptoms

GenomeRNAi Phenotypes related to Apraxia according to GeneCards Suite gene sharing:

26
idDescriptionGenomeRNAi Source AccessionScoreTop Affiliating Genes
1GR00114-A10.6ATM, PNKP

MGI Mouse Phenotypes related to Apraxia according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053949.3APOE, CNTNAP2, MAPT
2MP:00030128.8APOE, C9orf72, ERC1, GRN, MAPT, NPHP1
3MP:00053847.7APOE, APTX, ATM, C9orf72, CNTNAP2, GRN

Drugs & Therapeutics for Apraxia

About this section

Drugs for Apraxia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 41)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
AcetylcholineapprovedPhase 480551-84-3187
Synonyms:
ACh
Acetyl choline ion
Acetylcholine Chloride
Acetylcholine cation
 
Acetylcholinium: acetyl-Choline
Choline acetate
Choline acetate (ester)
O-Acetylcholine
acetylcholine chloride
2
TolvaptanapprovedPhase 490150683-30-0216237
Synonyms:
( -)-4'-((7-Chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl)carbonyl)-o-tolu-m-toluidide
150683-30-0
7-Chloro-5-hydroxy-1-(2-methyl-4-(2-methylbenzoylamino)benzoyl)2,3,4,5-tetrahydro-1H-1-benzazepine
AC1L50C9
C116664
CHEBI:327437
CHEMBL344159
CID216237
 
L001628
N-[4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)-3-methylphenyl]-2-methylbenzamide
OPC 41061
OPC-41061
PDSP1_001738
PDSP2_001721
Samsca
Tolvaptan
UNII-21G72T1950
benzazepine derivative, 32
3Neurotransmitter AgentsPhase 4, Phase 218340
4abobotulinumtoxinAPhase 4652
5onabotulinumtoxinAPhase 4652
6incobotulinumtoxinAPhase 4662
7Cholinergic AgentsPhase 43992
8Botulinum ToxinsPhase 4697
9Botulinum Toxins, Type APhase 4657
10Liver ExtractsPhase 44067
11VasopressinsPhase 4294
12HormonesPhase 414415
13Natriuretic AgentsPhase 41697
14Arginine VasopressinPhase 4299
15
EthanolapprovedPhase 3213764-17-5702
Synonyms:
(C6-C9)Alkyl alcohol
02483_FLUKA
02851_FLUKA
02853_FLUKA
02854_FLUKA
02855_FLUKA
02856_FLUKA
02856_SIAL
02857_FLUKA
02857_SIAL
02858_FLUKA
02858_SIAL
02860_FLUKA
02865_FLUKA
02865_SIAL
02870_FLUKA
02870_SIAL
02875_FLUKA
02877_FLUKA
02878_FLUKA
02882_FLUKA
02882_SIAL
02883_FLUKA
02884_FLUKA
02890_FLUKA
02890_SIAL
02891_FLUKA
02891_SIAL
1-Hydroxyethane
100C.NPA
121182-78-3
187380_ALDRICH
187380_SIAL
24102_RIEDEL
24102_SIAL
24103_RIEDEL
24103_SIAL
24105_RIEDEL
24105_SIAL
24106_RIEDEL
24106_SIAL
24194_RIEDEL
24194_SIAL
245119_ALDRICH
245119_SIAL
270741_ALDRICH
270741_SIAL
277649_ALDRICH
277649_SIAL
2858_SIGMA
29221_FLUKA
32205_RIEDEL
32205_SIAL
32221_RIEDEL
32221_SIAL
32294_RIEDEL
32294_SIAL
34870_SIAL
34963_RIEDEL
39278_FLUKA
40210_ALDRICH
40210_RIEDEL
41322_FLUKA
458600_ALDRICH
458600_SIAL
459828_ALDRICH
459828_SIAL
459836_ALDRICH
459836_SIAL
459844_SIAL
48075_SUPELCO
493511_SIAL
493538_ALDRICH
493538_SIAL
493546_ALDRICH
493546_SIAL
64-17-5
676829_SIAL
68475-56-9
71076-86-3
71329-38-9
8000-16-6
8024-45-1
AC1L19TW
AC1Q31MM
AHD 2000
AI3-01706
ALCOHOL 5% IN D5-W
Absolute Alcohol
Absolute Ethanol
Absolute alcohol
Absolute ethanol
Absolute ethyl alcohol
Aethanol
Aethanol [German]
Aethylalkohol
Alcare Hand Degermer
Alcohol
Alcohol (USP)
Alcohol (ethyl)
Alcohol Anhydrous
Alcohol [USP]
Alcohol anhydrous
Alcohol dehydrated
Alcohol denatured
Alcohol etílico
Alcohol, Absolute
Alcohol, Dehydrated
Alcohol, Diluted
Alcohol, Grain
Alcohol, anhydrous
Alcohol, dehydrated
Alcohol, denatured
Alcohol, diluted
Alcohol, ethyl
Alcohols
Alcohols, C1-3
Alcohols, C30
Alcohols, C6-9
Alcool Ethylique
Alcool Etilico
Alcool ethylique
Alcool etilico
Alcool éthylique
Algrain
Alkohol
Alkohol [German]
Alkoholu Etylowego
Alkoholu etylowego
Aminoethanol
Anhydrol
Anhydrol PM 4085
Anhydrous alcohol
Anhydrous ethanol
Beta-Aminoethanol
Beta-Aminoethyl Alcohol
Beta-Ethanolamine
Beta-Hydroxyethylamine
C00469
C2H5OH
C2H6O
CCRIS 945
CDA 19
CDA 19-200
CHEBI:16236
CHEMBL545
CID702
Caswell No. 426
Caswell No. 430
Colamine
Cologne Spirit
Cologne spirit
Cologne spirits
 
D000431
D00068
DB00898
Dehydrated Ethanol
Dehydrated alcohol
Dehydrated ethanol
Denatured Alcohol
Denatured Alcohol Cd-10
Denatured Alcohol Cd-5
Denatured Alcohol Cd-5a
Denatured Alcohol Sd-1
Denatured Alcohol Sd-13a
Denatured Alcohol Sd-17
Denatured Alcohol Sd-23a
Denatured Alcohol Sd-28
Denatured Alcohol Sd-30
Denatured Alcohol Sd-39b
Denatured Alcohol Sd-39c
Denatured Alcohol Sd-3a
Denatured Alcohol Sd-40m
Denatured Ethanol
Denatured alcohol
Denatured ethanol
Desinfektol EL
Diluted Alcohol
Distilled spirits
E2385_SIGMA
E7023_ALDRICH
E7023_SIAL
E7148_ALDRICH
E7148_SIAL
E7517_SIGMA
EINECS 200-578-6
EINECS 270-649-4
EOH
EOX
ETA
Envision Conditioner Pdd 9020
Esumiru WK 88
EtOH
Etanolo
Etanolo [Italian]
Ethanol (9CI)
Ethanol 200 Proof
Ethanol 200 proof
Ethanol Absolute
Ethanol Absolute Bp
Ethanol Anhydrous
Ethanol Extra Pure
Ethanol Vapor
Ethanol [JAN]
Ethanol solution
Ethanol, Silent Spirit
Ethanol, undenatured
Ethanolum anhydricum
Ethicap
Ethyl Alcohol
Ethyl Alcohol & Water, 10%
Ethyl Alcohol & Water, 20%
Ethyl Alcohol & Water, 30%
Ethyl Alcohol & Water, 40%
Ethyl Alcohol & Water, 5%
Ethyl Alcohol & Water, 50%
Ethyl Alcohol & Water, 60%
Ethyl Alcohol & Water, 70%
Ethyl Alcohol & Water, 80%
Ethyl Alcohol & Water, 95%
Ethyl Alcohol & Water, 96%
Ethyl Alcohol Anhydrous
Ethyl Alcohol, Anhydrous
Ethyl Alcohol, Denatured
Ethyl Hydrate
Ethyl Hydroxide
Ethyl alc
Ethyl alcohol
Ethyl alcohol anhydrous
Ethyl alcohol in alcoholic beverages
Ethyl alcohol usp
Ethyl hydrate
Ethyl hydroxide
Ethylalcohol
Ethylalcohol [Dutch]
Ethylol
Ethylolamine
Ethyloxy Group
Etylowy alkohol
FEMA No. 2419
FEMA Number 2419
Fermentation alcohol
Glycinol
Grain alcohol
HSDB 531
HSDB 82
HYDROXYETHYL GROUP
Hinetoless
Hydroxyethane
I14-12648
IMS 99
Infinity Pure
Jaysol
Jaysol S
LS-1539
LTBB002977
Lux
Methylated Spirit Mineralised
Methylated spirit
Methylcarbinol
MolPort-001-785-844
Molasses alcohol
NCGC00091458-01
NCI-C03134
NSC 85228
NSC85228
Oxydimethylene Group
Potato alcohol
Punctilious ethyl alcohol
Pyro
QMHAIh@
Reagent Alcohol
Ru-Tuss Expectorant
SDA 3A
SDA 40-2
SDM No. 37
SY Fresh M
Sekundasprit
Silent spirit
Spirit
Spirits of wine
Spiritus vini
Spirt
Synasol
Tecsol
Tecsol C
Thanol
Thiofaco M-50
UNII-3K9958V90M
USAF EK-1597
Undenatured Ethanol
WLN: Q2
absolute alcohol
alcohol
alcohol etilico
bmse000297
etanol
ethanol
ethyl alcohol
grain alcohol
nchem.651-comp3c
nchembio.552-comp10
nchembio.94-comp20
spiritus vini
Äthanol
Äthylalkohol
éthanol
16
Glycerolexperimental, approvedPhase 323856-81-5753
Synonyms:
1,2,3-Trihydroxypropane
1,2,3-propanetriol
1,2,3-trihydroxypropane
Bulbold
Cristal
E 422
Emery 916
Glyceol Opthalgan
Glycerin
Glycerin, anhydrous
Glycerin,anhydrous
Glycerine
Glycerinum
 
Glyceritol
Glycerol
Glycyl alcohol
Glyrol
Glysanin
IFP
Incorporation factor
Mackstat H 66
Monoctanoin component D
Osmoglyn
Pricerine 9091
Propanetriol
RG-S
Trihydroxypropane
Tryhydroxypropane
17UbiquinonePhase 3145
18MicronutrientsPhase 36001
19VitaminsPhase 35282
20Trace ElementsPhase 36001
21Complement System ProteinsPhase 3232
22LecithinNutraceuticalPhase 374
23
Coenzyme Q10experimental, NutraceuticalPhase 3121303-98-05281915
Synonyms:
(all-E)-2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31-octamethyl-2,6,10,14,18,22,26,30-dotriacontaoctaenyl)-2,5-Cyclohexadiene-1,4-dione
(all-E)-2-(3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-2,5-Cyclohexadiene-1,4-dione
2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-p-Benzoquinone
2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl]-5,6-dimethoxy-3-methyl- 2,5-Cyclohexadiene-1,4-dione
4-Ethyl-5-fluoropyrimidine
Aqua Q 10L10
Aqua Q10
Bio-Quinon
Bio-Quinone Q10
CoQ10
Coenzyme Q-10
Coenzyme Q10
Ensorb
Kaneka Q10
 
Kudesan
Li-Q-Sorb
Liquid-Q
Neuquinon
Neuquinone
PureSorb Q 40
Q 10AA
Q-Gel
Q-Gel 100
Ubidecarenone
Ubiquinone 10
Ubiquinone 50
Ubiquinone Q10
Ubiquinone-10
Unbiquinone
Unispheres Q 10
24
Memantineapproved, investigationalPhase 218119982-08-24054
Synonyms:
1,3-Dimethyl-5-adamantanamine
1-Amino-3,5-dimethyladamantane
19982-08-2
3,5-Dimethyl-1-adamantanamine
3,5-Dimethyl-1-adamantylamine
3,5-Dimethyl-1-aminoadamantane
3,5-Dimethyladamantan-1-ylamine
3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine
3,5-dimethyladamantan-1-amine
3,5-dimethyltricyclo[3.3.1.1~3,7~]decan-1-amine
41100-52-1 (Hydrochloride)
51052-62-1
AB00053600
AC1L1HB7
AKOS000113995
BBL000737
BPBio1_001117
BPBio1_001270
BSPBio_001015
Biomol-NT_000209
C13736
CBMicro_020348
CHEBI:152523
CHEMBL807
CID4054
D08174
DB01043
DMAA
DivK1c_000068
EU-0053634
Ebixa
Exiba
Exiba (TN)
HMS500D10
HSDB 7327
IDI1_000068
KBio1_000068
KBio2_001087
KBio2_003655
 
KBio2_006223
KBio3_001926
KBioGR_001543
KBioSS_001087
LS-157051
Lopac0_000861
Memantin
Memantina
Memantina [INN-Spanish]
Memantine
Memantine (INN)
Memantine HCL
Memantine Hydrochloride
Memantine [INN:BAN]
Memantine [INN]
Memantinum
Memantinum [INN-Latin]
MolPort-002-041-858
NCGC00015705-05
NCGC00024782-02
NCGC00024782-03
NINDS_000068
Namenda
Oprea1_480562
Prestwick0_000978
Prestwick1_000978
Prestwick2_000978
Prestwick3_000978
SPBio_001456
SPBio_002926
ST057652
STK520682
Spectrum2_001408
Spectrum3_000923
Spectrum4_001022
Spectrum5_001355
Spectrum_000607
UNII-W8O17SJF3T
ZERO/006024
memantine
25
DopamineapprovedPhase 2383651-61-6, 62-31-7681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
KBio1_000780
 
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
26
BenzocaineapprovedPhase 220161994-09-7, 94-09-72337
Synonyms:
(p-(Ethoxycarbonyl)phenylamine
06952_FLUKA
112909_ALDRICH
112909_SIAL
1333-08-0
23239-88-5
23239-88-5 (hydrochloride)
4 Aminobenzoic Acid Ethyl Ester
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-14-00-01129 (Beilstein Handbook Reference)
4-Aminobenzoate
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Aminobenzoic acid, ethyl ester
4-Carbethoxyaniline
4-amino-benzoic acid ethyl ester
4-aminobenzoic acid ethyl ester
71123-91-6
94-09-7
94-09-7 (Parent)
A0271
AB00051923
AC1L1DGC
AC1Q341A
AC1Q64JE
AE-562/40377256
AI3-02081
AKOS000119763
AR-1H9065
Acetate, Benzocaine
Aethoform
Aethylium paraminobenzoicum
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthesinum
Anaesthin
Anestezin
Anestezin [Russian]
Anesthesin
Anesthesine
Anesthone
BB_SC-0019
BPBio1_001017
BRD-K75466013-001-05-2
BRN 0638434
BSPBio_000923
BSPBio_001908
Baby Anbesol
Bensokain
Benzoak
Benzocaina
Benzocaina [INN-Spanish]
Benzocaine
Benzocaine (USP/INN)
Benzocaine Acetate
Benzocaine Formate
Benzocaine Hydrobromide
Benzocaine Hydrochloride
Benzocaine Methanesulfonate
Benzocaine [INN:BAN]
Benzocainum
Benzocainum [INN-Latin]
Benzoic acid, 4-amino-, ethyl ester
Benzoic acid, 4-amino-, ethyl ester, hydrochloride
Benzoic acid, amino-, ethyl ester
Benzoic acid, p-amino-, ethyl ester
C07527
CAS-94-09-7
CHEBI:116735
CHEMBL278172
CID2337
Caswell No. 430A
Chloraseptic
D001566
D00552
DB01086
Dermoplast
Diet Ayds
DivK1c_000932
E1501_SIGMA
EINECS 202-303-5
EPA Pesticide Chemical Code 097001
ETHYL-P-AMINOBENZOATE
Ethoform
Ethoforme
Ethyl 4-aminobenzoate
Ethyl 4-aminobenzoate hydrochloride
Ethyl 4-aminobenzoic acid
Ethyl Aminobenzoate
Ethyl PABA
 
Ethyl aminobenzoate
Ethyl aminobenzoate (JP15)
Ethyl aminobenzoate (VAN)
Ethyl aminobenzoic acid
Ethyl p-Aminobenzoate
Ethyl p-Aminophenylcarboxylate
Ethyl p-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethylester kyseliny p-aminobenzoove
Ethylester kyseliny p-aminobenzoove [Czech]
Ethylis aminobenzoas
Formate, Benzocaine
HMS1570O05
HMS1920G09
HMS2091M11
HMS502O14
HSDB 7225
Hurricaine
Hydrobromide, Benzocaine
Hydrochloride, Benzocaine
I05-0204
IDI1_000932
Identhesin
KBio1_000932
KBio2_000474
KBio2_003042
KBio2_005610
KBio3_001408
KBioGR_000658
KBioSS_000474
Keloform
LS-35847
MLS001331704
MLS002153970
Methanesulfonate, Benzocaine
MolPort-000-871-526
NCGC00016352-01
NCGC00094598-01
NCGC00094598-02
NINDS_000932
NSC 122792
NSC 41531
NSC41531
NSC4688
Norcain
Norcaine
Norcainum
Oprea1_750694
Oprea1_827402
Ora-jel
Orabase-B
Orthesin
Otocain
Outgro
Parathesin
Parathesin (TN)
Parathesine
Prestwick0_000712
Prestwick1_000712
Prestwick2_000712
Prestwick3_000712
Prestwick_991
SMR000059025
SPBio_000134
SPBio_002844
SPECTRUM1500139
STK043620
Slim Mint Gum
Solarcaine
Solu H
Spectrum2_000117
Spectrum3_000314
Spectrum4_000249
Spectrum5_000860
Spectrum_000074
Topcaine
UNII-U3RSY48JW5
WLN: ZR DVO2
ZINC12358719
benzocaine
ethylaminobenzoate-4
h-4-abz-oet
nchembio.182-comp4
p-(Ethoxycarbonyl)aniline
p-Aminobenzoate
p-Aminobenzoic acid
p-Aminobenzoic acid ethyl ester
p-Aminobenzoic acid, ethyl ester
p-Aminobenzoic ethyl ester
p-Carbethoxyaniline
p-Ethoxycarboxylic Aniline
p-Ethoxycarboxylic aniline
27tannic acidapproved, NutraceuticalPhase 22016
28Excitatory Amino AcidsPhase 21362
29Antiparkinson AgentsPhase 21574
30Dopamine AgentsPhase 23836
31Excitatory Amino Acid AntagonistsPhase 21347
32DeoxyglucosePhase 1123
33Fluorodeoxyglucose F18Phase 1412
34
CorticosteronePhase 11150-22-65753
Synonyms:
11,21-Dihydroxypregn-4-ene-3,20-dione
11,21-Dihydroxyprogesterone
11-Hydroxycorticoaldosterone
 
17-Deoxycortisol
4-Pregnene-11 Corticosteron
Corticosterone
Kendall'S compound B
Reichstein'S substance H
35
Mentholapproved26062216-51-516666
Synonyms:
(−
()-Menthol
(+)-Neo-menthol
(+)-p-Menthan-3-ol
(+-)-(1R*,3R*,4S*)-Menthol
(+-)-Menthol
(+/-)-Menthol
(+/-)-p-Menthan-3-ol
(-)-(1R,3R,4S)-Menthol
(-)-Menthyl alcohol
(-)-menthol
(-)-p-Menthan-3-ol
(-)-trans-p-Menthan-cis-ol
(1R)-(-)-Menthol
(1R,2S,5R)-(-)-menthol
(1R,2S,5R)-Menthol
(1R,3R,4S)-(-)-MENTHOL
(1R,3R,4S)-(-)-Menthol
(1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol
(1S, 2S, 5R)-(+)-Neomenthol
(1S,2R,5R)-(+)-Isomenthol
(1S,2R,5S)-(+)-Menthol
(1S,2R,5S)-Menthol
(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol
(1r,2s,5r)-(-)-menthol
(L)-MENTHOL
(R)-(-)-Menthol
(r)-(-)-menthol
)-Menthol
--MENTHOL
1-Menthol
1490-04-6
15356-60-2
15356-70-4
15785_RIEDEL
15785_SIAL
19863P
2-Isopropyl-5-methylcyclohexanol
20747-49-3
2216-51-5
3-p-Menthol
4-Isopropyl-1-methylcyclohexan-3-ol
491-02-1
5-Methyl-2-(1-methylethyl)-cyclohexanol
5-Methyl-2-(1-methylethyl)cyclohexanol
5-methyl-2-(propan-2-yl)cyclohexanol
5-methyl-2-propan-2-ylcyclohexan-1-ol
551376_ALDRICH
551376_FLUKA
588733_ALDRICH
613290_ALDRICH
613290_FLUKA
63660_FLUKA
63670_ALDRICH
63670_FLUKA
63975-60-0
6C6A4A8C-A054-468C-A1F0-F29E39838CF2
89-78-1
98167-53-4
AC1L1B2E
AC1L28FR
AC1Q1NQ2
AC1Q2QQM
AI3-08161
AI3-52408
AKOS000119740
AR-1J3337
BB_NC-0057
BRN 1902288
BRN 3194263
BSPBio_003062
C00400
C10H20O
CCRIS 3728
CCRIS 375
CCRIS 4666
CCRIS 9231
CHEBI:15409
CHEBI:545611
CHEMBL256087
CHEMBL470670
CID1254
CID16666
Caswell No. 540
D-(-)-Menthol
D-p-Menthan-3-ol
D00064
D008610
D04849
D04918
DB00825
DivK1c_000820
EINECS 201-939-0
EINECS 207-724-8
EINECS 216-074-4
EINECS 218-690-9
EINECS 239-387-8
EINECS 239-388-3
EPA Pesticide Chemical Code 051601
FEMA No. 2665
Fisherman's friend lozenges
Fisherman's friend lozenges (TN)
HMS1922G13
HMS2092L14
HMS502I22
 
HSDB 5662
HSDB 593
Headache crystals
Hexahydrothymol
I06-1216
I14-7371
IDI1_000820
KBio1_000820
KBio2_000785
KBio2_003353
KBio2_005921
KBio3_002562
KBioSS_000785
L-(-)-Menthol
L-(-)-menthol
L-Menthol
L-menthol
LMPR0102090001
LS-2353
LS-57201
LS-886
LS-89531
LS-89533
Levomenthol
Levomenthol [INN:BAN]
Levomentholum
Levomentholum [INN-Latin]
Levomentol
M0321
M0545
M2772_SIAL
MENTHOL
MLS002207256
Menthacamphor
Menthol
Menthol (USP)
Menthol (VAN)
Menthol natural
Menthol natural, brazilian
Menthol racemic
Menthol racemique
Menthol racemique [French]
Menthol solution
Menthol, (1alpha,2beta,5alpha)-Isomer
Menthomenthol
Menthyl alcohol
MolPort-000-849-729
MolPort-001-793-392
NCGC00159382-02
NCGC00159382-03
NCGC00164247-01
NCGC00164247-02
NCI-C50000
NINDS_000820
NOOLISFMXDJSKH-KXUCPTDWBX
NSC 2603
NSC 62788
NSC2603
NSC62788
Neoisomenthol
Peppermint camphor
RACEMIC MENTHOL U.S.P.
Racementhol
Racementhol [INN:BAN]
Racementholum
Racementholum [INN-Latin]
Racementol
Racementol [INN-Spanish]
Racemic menthol
Robitussin Cough Drops
SDCCGMLS-0066659.P001
SMR001306785
SPBio_000869
SPECTRUM1503134
STK802468
Spectrum2_000855
Spectrum3_001561
Spectrum5_001060
Spectrum_000305
Tra-kill tracheal mite killer
U.S.P. Menthol
U.S.p. Menthol
UNII-BZ1R15MTK7
UNII-L7T10EIP3A
UNII-YS08XHA860
W266507_ALDRICH
W266523_ALDRICH
W266590_ALDRICH
WLN: L6TJ AY1&1 BQ D1
WLN: L6TJ AY1&1 DQ D1 -L
ZINC01482164
cis-1 ,3-trans-1,4-(+-)-menthol
cis-1,3-trans-1,4-(+-)-menthol
d,l-Menthol
d-Menthol
d-Neomenthol
dl-3-p-Menthanol
dl-Menthol
dl-Menthol (JP15)
l-(-)-Menthol
l-Menthol
l-Menthol (JP15)
l-Menthol (TN)
l-Menthol (natural)
nchembio862-comp1
p-Menthan-3-ol
rac-Menthol
36
Ergocalciferolapproved, nutraceutical128150-14-65280793
Synonyms:
'Ergosterol irradiated'
(+)-Vitamin D2
(3-beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10,(19),22-tetraen-3-ol
(3S,5Z,7E,14xi,17alpha,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3beta,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
(5E,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
22-Tetraen 3beta 9,10,Secoergosta-5,7,10(19)-ol
31316-19-5
4-Methylene-3-[2-[tetrahydro-7a-methyl-1-(1,4,5-trimethyl-2-hexenyl)-4(3aH)-indanylidene]ethylidene]-Cyclohexanol
47768_SUPELCO
50-14-6
7489-18-1
7E677DC1-E1C4-4FC5-8F4A-BCE1857F7E87
8017-28-5
9,10,Secoergosta-5,7,10(19),22-tetraen 3.beta.-ol
9,10-Seco(5Z,7E,22E)-5,7,10(19),22-ergostatetraen-3-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3-beta-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3b-ol
95220_FLUKA
95220_SIGMA
AC-1355
AC1L1FIE
AC1NQXLH
AC1NS4DE
AC1NS9GI
AC1NSSVD
AC1NWAM3
AC1O5EDK
AC1O6WAM
ACon1_002187
Activated ergosterol
BPBio1_000418
BSPBio_000380
BSPBio_001974
Buco-D
C05441
C28H44O
CALCIFEROL IN A GELATIN MATRIX
CALCIFEROL, U.S.P.
CHEBI:28934
CHEMBL1536
CID11003810
CID3249
CID5280793
CID5315257
CID5353610
CID5356615
CID5702050
CID6432478
CID6536972
Calciferol
Calciferol (TN)
Calciferol (vitamin D2)
Calciferolum
Calciferon 2
Condacaps
Condocaps
Condol
Crtron
Crystallina
D-Arthin
D-Tracetten
D00187
DB00153
Daral
Davitamon D
Davitin
De-rat concentrate
Decaps
Dee-Osterol
Dee-Ron
Dee-Ronal
Dee-Roual
Deltalin
Deratol
Detalup
Diactol
Divit urto
Doral
Drisdol
Drisdol (TN)
E5750_SIGMA
EINECS 200-014-9
Ercalciol
Ergocalciferol
Ergocalciferol (D2)
Ergocalciferol (JP15/USP)
Ergocalciferol [INN:BAN:JAN]
Ergocalciferol oil
Ergocalciferol: Vitamin D
 
Ergocalciferolo
Ergocalciferolo [DCIT]
Ergocalciferols
Ergocalciferolum
Ergocalciferolum [INN-Latin]
Ergorone
Ergosterol activated
Ergosterol irradiated
Ergosterol, irradiated
Ertron
Fortodyl
Geltabs
Geltabs Vitamin D
HMS1920K20
HMS2091B19
HMS502I07
HSDB 819
Haliver
Hi-Deratol
Hyperkil
I05-0022
IDI1_000805
Infron
Irradiated ergosta-5,7,22-trien-3-beta-ol
Irradiated ergosta-5,7,22-trien-3.beta.-ol
Irradiated ergosta-5,7,22-trien-3beta-ol
Irradiated ergosterol
LMST03010001
LMST03010014
LS-3228
MEGxm0_000466
MLS001332467
MLS001332468
Metadee
Mina D2
MolPort-001-740-057
MolPort-001-793-930
MolPort-002-526-645
MolPort-003-666-178
MolPort-006-822-629
Mulsiferol
Mykostin
NCGC00142497-01
NCGC00179579-01
NCGC00179579-02
NSC 62792
NSC62792
Novovitamin-D
Oleovitamin D
Oleovitamin D, Synthetic
Oleovitamin D2
Osteil
Ostelin
Prestwick3_000420
Prestwick_554
Radiostol
Radstein
Radsterin
Rodine C
Rodinec
SMR000857106
SPECTRUM1500276
ST057150
STOCK1N-53397
Shock-ferol
Shock-ferol sterogyl
Sorex C.R
Sorex C.R.
Spectrum5_000666
Sterogyl
Synthetic Vitamin D
UNII-VS041H42XC
Uvesterol D
Uvesterol-D
VITAMIN D2
VITAMIN D2 WATER DISPERSABLE U.S.P.
VITAMIN_D2
Vigantol
Vio D
Vio-D
Viostdrol
Viosterol
Viosterol in Oil
Vitamin D2
Vitamin- D2
Vitamin-?D2
Vitamina D2
Vitavel-D
WLN: L56 FYTJ A1 BY1&1U1Y1&Y1&1 FU2U- BL6YYTJ AU1 DQ
ZINC04474571
ZINC04629876
beta-Ol
bmse000510
component of Geltabs Vitamin D
delta-Arthin
delta-Tracetten
ergocalciferol
vitamin d-2
37Ergocalciferols1281
38vitamin d1724
39Bone Density Conservation Agents3376
40Vitamin D2Nutraceutical1281
41CalciferolNutraceutical1383

Interventional clinical trials:

(show all 50)
idNameStatusNCT IDPhase
1The Use of Botox in Advanced Parkinson's Patients Experiencing PainUnknown statusNCT02472210Phase 4
2Tolvaptan to Reduce Length of Stay in Hospitalized Patients With Cirrhosis and HyponatremiaTerminatedNCT01890694Phase 4
3Evolution of Albumin on AOA1 Patients Supplemented With Coenzyme Q10RecruitingNCT02333305Phase 3
4Electrical Polarization of the Brain in Corticobasal SyndromeCompletedNCT00273897Phase 2
5A Safety and Tolerability Study of JNJ-54861911 in Participants With Early Alzheimer's DiseaseCompletedNCT02260674Phase 2
6A Multi-site Double-blind Placebo-controlled Trial of Memantine Versus Placebo in Children With Autism (MEM)CompletedNCT01372449Phase 2
7Evaluating Anodal tDCS Preceding Aphasia TherapyRecruitingNCT02249819Phase 1, Phase 2
8Treatment of Mitochondrial Dysfunction in Rett Syndrome With TriheptanoinRecruitingNCT02696044Phase 2
9PiB PET Scanning in Speech and Language Based DementiasCompletedNCT01623284Phase 1
10Apraxia of Speech: Comparison of EPG Treatment (Tx) and Sound Production Treatment (SPT)RecruitingNCT02554513Phase 1
11Intervention on Caregivers Caring for Patients Poststroke With Upper Limb ApraxiaUnknown statusNCT02307019
12Construction-LBD (Constructional Apraxia in Alzheimer's Disease (AD) and Lewy Body's Dementia (LBD))Unknown statusNCT01993628
13Action Observation Treatment (AOT) as a Rehabilitation ToolUnknown statusNCT02235350
14Scholar Performance and Praxis Assessment in Children With Rolandic EpilepsyUnknown statusNCT01046760
15Transcranial and Rapid Magnetic Stimulation for Gait Apraxia Due to Normal Pressure Hydrocephalus and Cerebral IschemiaUnknown statusNCT00494689
16Study of Adherence and Effects of Balance Exercices (SIEL BLEU Associatio)Unknown statusNCT01314638
17Rehabilitation Combined With Bihemispherictranscranial Direct Current Stimulation in Subacute Ischemic StrokeUnknown statusNCT01644929
18Cognitive Assessment for Stroke Patients: Reproductibility and Validity StudyUnknown statusNCT01904799
19EEG and EMG Analysis of Ideomotor ApraxiaCompletedNCT00024999
20Auditory Masking Effects on Speech Fluency in Aphasia and Apraxia of SpeechCompletedNCT02094014
21Occupational Therapy in Patients With Multiple SclerosisCompletedNCT01507636
22Stuttering and Apraxia of Speech: the Efficacy of an Intervention ProgramCompletedNCT01097161
23Using fMRI to Understand the Roles of Brain Areas for Fine Hand MovementsCompletedNCT00063115
24Gait and Alzheimer Interaction Tracking (GAIT) StudyCompletedNCT01315717
25Orientation Agnosia: Clinical and Anatomical StudyCompletedNCT01304576
26Clinical Findings in General ParesisCompletedNCT00921648
27Upper Limbs Intervention in Multiple SclerosisCompletedNCT02047825
28Deep Brain Stimulation for Patients With Dementia With Lewy BodiesCompletedNCT02263937
29Treatment Intensity - Apraxia of SpeechRecruitingNCT02332915
30Longitudinal Multi-Modality Imaging in Progressive Apraxia of SpeechRecruitingNCT01818661
31Brain Biomarkers of Response to Treatment for Apraxia of SpeechRecruitingNCT02046941
32Evaluation of Intensive Language TherapyRecruitingNCT02935842
33Memory for Action in Neurological PatientsRecruitingNCT02844855
34Alzheimer's Disease and Related DisordersRecruitingNCT01315704
35Early-onset Alzheimer's Disease Phenotypes: Neuropsychology and Neural NetworksRecruitingNCT03153371
36Build-up of Action Representation in Autism Spectrum DisordersRecruitingNCT03108976
37Language and Motricity in Preterm School Age ChildrenRecruitingNCT02811029
38Gait as Predictor of Dementia and Falls. The Gait and Brain Cohort StudyRecruitingNCT03020381
39Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordRecruitingNCT01793168
40Blepharospasm ToolsRecruitingNCT02780336
41Rehabilitative Trial With Cerebello-Spinal tDCS in Neurodegenerative AtaxiaRecruitingNCT03120013
42Functional Rehabilitation of Upper Limb Apraxia in Patients PoststrokeActive, not recruitingNCT02199093
43Treatments of Acquired Apraxia of SpeechActive, not recruitingNCT01483807
44A Novel Treatment for Aphasia and Apraxia of Speech : Measurement of OutcomesActive, not recruitingNCT01979159
45Clinical and Molecular Investigations Into CiliopathiesActive, not recruitingNCT00068224
46Exploring the Impact and Feasibility of a Pathway to Sport and Long-term Participation in Young PeopleEnrolling by invitationNCT02517333
47Transcranial Magnetic Stimulation (TMS) for Primary Progressive Apraxia of Speech (PPAOS)Not yet recruitingNCT03028324
48Rehabilitation Gaming System for Cerebral PalsyNot yet recruitingNCT02938754
49Transcranial Magnetic Stimulation in Nonfluent/Agrammatic Variant Primary Progressive AphasiaNot yet recruitingNCT03153540
50Central Mechanisms in Speech Motor Control Studied With H215O PETTerminatedNCT00001308

Search NIH Clinical Center for Apraxia

Genetic Tests for Apraxia

About this section

Genetic tests related to Apraxia:

id Genetic test Affiliating Genes
1 Apraxia27

Anatomical Context for Apraxia

About this section

MalaCards organs/tissues related to Apraxia:

36
Brain, Parietal lobe, Cortex, Eye, Tongue, Testes, Subthalamic nucleus

Publications for Apraxia

About this section

Articles related to Apraxia:

(show top 50)    (show all 731)
idTitleAuthorsYear
1
Apraxia of speech and cerebellar mutism syndrome: a case report. (28074148)
2017
2
Callosal ideomotor apraxia in Alzheimer's disease. (27829324)
2017
3
Combined aphasia and apraxia of speech treatment (CAAST): Systematic replications in the development of a novel treatment. (28084854)
2017
4
Erratum to: Ataxia with Oculomotor Apraxia Type 1 without Oculomotor Apraxia: A Case Report. (28079319)
2017
5
Response to Letter Regarding Article, "Damage to the Left Precentral Gyrus Is Associated With Apraxia of Speech in Acute Stroke". (26965848)
2016
6
A novel SETX gene mutation producing ataxia with oculomotor apraxia type 2. (26811093)
2016
7
Childhood apraxia of speech: A survey of praxis and typical speech characteristics. (27241138)
2016
8
Articulatory Control in Childhood Apraxia of Speech in a Novel Word-Learning Task. (27750297)
2016
9
Apraxia of eyelid closure in a case of post-Japanese encephalitis Parkinsonism. (27147166)
2016
10
Ideomotor limb apraxia as a staging tool in individuals with Alzheimer's disease (ILIAD). (27901517)
2016
11
The Use of Electropalatography in the Treatment of Acquired Apraxia of Speech. (27997947)
2016
12
The magnetic apraxia of Denny-Brown. (27502963)
2016
13
Diagnostic Distortions: A Case Report of Progressive Apraxia of Speech. (27104903)
2016
14
Limb-kinetic apraxia affects activities of daily living in Parkinson's disease: a multi-center study. (27132653)
2016
15
A highly penetrant form of childhood apraxia of speech due to deletion of 16p11.2. (26763793)
2016
16
Cognitive, Linguistic, and Motor Abilities in a Multigenerational Family with Childhood Apraxia of Speech. (27707700)
2016
17
Telehealth delivery of Rapid Syllable Transitions (ReST) treatment for childhood apraxia of speech. (27161038)
2016
18
Ideomotor Apraxia Due to Injury of the Superior Longitudinal Fasciculus: A Case Report. (27003199)
2016
19
Reliability and Validity of Korean Version of Apraxia Screen of TULIA (K-AST). (27847706)
2016
20
Hot topic: PNKP mutations cause ataxia with oculomotor apraxia type 4. (26970421)
2016
21
Frontalis suspension surgery to treat patients with blepharospasm and eyelid opening apraxia: long-term results. (27816991)
2016
22
Bridging the Gap Between Speech and Language: Using Multimodal Treatment in a Child With Apraxia. (27492818)
2016
23
Callosal apraxia: a 34-year follow-up study. (26928117)
2016
24
Improved Necker Cube Drawing-Based Assessment Battery for Constructional Apraxia: The Mie Constructional Apraxia Scale (MCAS). (27790241)
2016
25
Primary Progressive Orofacial Apraxia: AA Ten-Year Long Follow-Up Case Report. (27567870)
2016
26
Oculomotor apraxia and dilated cardiomyopathy with ataxia syndrome: A case report. (27054461)
2016
27
Dysfunction of the Human Mirror Neuron System in Ideomotor Apraxia: Evidence from Mu Suppression. (26942323)
2016
28
Utility of testing for apraxia and associated features in dementia. (27251676)
2016
29
Genetic Candidate Variants in Two Multigenerational Families with Childhood Apraxia of Speech. (27120335)
2016
30
Brothers with ocular motor apraxia, juvenile nephronophthisis, and mild cerebellar defects. (27316287)
2016
31
Nosological delineation of congenital ocular motor apraxia type Cogan: an observational study. (27473762)
2016
32
Self-Judgments of Word Production Accuracy in Acquired Apraxia of Speech. (27997948)
2016
33
Letter by Terao et al Regarding Article, "Damage to the Left Precentral Gyrus Is Associated With Apraxia of Speech in Acute Stroke". (26965850)
2016
34
Treatments and technologies in the rehabilitation of apraxia and action disorganisation syndrome: A review. (27314872)
2016
35
Motor Speech Apraxia in a 70-Year-Old Man with Left Dorsolateral Frontal Arachnoid Cyst: A [(18)F]FDG PET-CT Study. (28003922)
2016
36
Shared neural correlates of limb apraxia in early stages of Alzheimer's dementia and behavioural variant frontotemporal dementia. (27639684)
2016
37
Progressive apraxia of speech in a patient with a C9orf72 mutation. (27166164)
2016
38
Recovering With Acquired Apraxia of Speech: The First 2 Years. (27997946)
2016
39
Expanding the phenotypic profile of Kleefstra syndrome: A female with low-average intelligence and childhood apraxia of speech. (26833960)
2016
40
When the left brain's away, the right will play - Emergent artistic proficiency in primary progressive apraxia of speech. (26775758)
2016
41
Balance impairment does not necessarily coexist with gait apraxia in mild and moderate Alzheimer's disease. (27332069)
2016
42
Brain damage associated with apraxia of speech: evidence from case studies. (27264534)
2016
43
Expanding the ataxia with oculomotor apraxia type 4 phenotype. (27066586)
2016
44
Post-stroke pure apraxia of speech - A rare experience. (27591108)
2016
45
Alternating hemiparesis and orolingual apraxia as manifestations of methotrexate neurotoxicity in a paediatric case of acute lymphoblastic leukaemia. (27113788)
2016
46
Perceptual decisions regarding object manipulation are selectively impaired in apraxia or when tDCS is applied over the left IPL. (27109034)
2016
47
Neuroanatomical correlates of childhood apraxia of speech: A connectomic approach. (27882295)
2016
48
Limb-Kinetic Apraxia Due to Injury of the Corticofugal Tract from the Secondary Motor Area in a Stroke Patient. (26945225)
2016
49
The clinical assessment of apraxia. (26984951)
2016
50
Clinical and MRI models predicting amyloid deposition in progressive aphasia and apraxia of speech. (26937376)
2016

Variations for Apraxia

About this section

Expression for genes affiliated with Apraxia

About this section
Search GEO for disease gene expression data for Apraxia.

Pathways for genes affiliated with Apraxia

About this section

Pathways related to Apraxia according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.6ATM, ERC1

GO Terms for genes affiliated with Apraxia

About this section

Cellular components related to Apraxia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1axolemmaGO:003067310.6CNTNAP2, MAPT
2cell projectionGO:00429959.3CEP104, CNTNAP2, MAPT, NPHP1, SETX
3cytoplasmGO:00057376.1APOE, APTX, ATM, C9orf72, CBS, CEP104

Biological processes related to Apraxia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1positive regulation of neuron deathGO:190121610.3ATM, MAPT
2lipoprotein catabolic processGO:004215910.2APOE, ATM
3cellular response to DNA damage stimulusGO:000697410.1APTX, ATM, PNKP, SETX
4DNA repairGO:00062819.9APTX, ATM, PNKP, SETX
5regulation of autophagyGO:00105069.7ATM, C9orf72, MAPT
6vocal learningGO:00422979.4CNTNAP2, FOXP2

Molecular functions related to Apraxia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1lipoprotein particle bindingGO:007181310.6APOE, MAPT
2protein bindingGO:00055155.2APOE, APTX, ATM, C9orf72, CBS, CEP104

Sources for Apraxia

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet